A growing number of global pharmaceutical companies are deploying SharePoint as the means to manage teams and projects.
Companies cite two principal reasons for adoption: one the need for a flexible platform that provides a basis for ad hoc collaboration of project teams without the intervention of IT, and two, the need to consolidate the plethora of legacy systems acquired over decades, which are expensive to maintain.
With the emergence of SharePoint as a viable ECM platform, pharmaceutical companies are evaluating its role in their enterprise content management architecture and strategy. Some believe that SharePoint’s role should be initially limited to accessing content stored in other environments, and there are tools available on the market to address that requirement. But, other companies are ready to make the move to using SharePoint to manage and store their regulated content. For those companies, it is encouraging that the market is responding with solutions targeted specifically at managing controlled content in pharmaceutical companies.
To learn more about USDM and how we can assist with your initiatives, please contact:
Rebecca Meledy
888.231.0816 x 161
775.213.5943 (fax)
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
"Simplify, Unify and Optimize your business & compliance needs with USDM"
SharePoint Pharmaceutical


